New weapon found to fight acute myeloid leukemia

Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found. Doctors said the findings should change the standard of care for younger adults with acute myeloid leukemia, but work remains to find better treatment for the elderly, who are more likely to develop the disease.

LOS ANGELES — Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found.

Doctors said the findings should change the standard of care for younger adults with acute myeloid leukemia, but work remains to find better treatment for the elderly, who are more likely to develop the disease.

Acute myeloid leukemia is a cancer of the blood and bone marrow. It’s the most common type of acute leukemia in adults. About 12,810 new cases will be diagnosed in the United States this year, according to the Leukemia&Lymphoma Society.

Patients typically receive two chemotherapy drugs to slow or stop the growth of cancer cells in the body. Two studies published in Thursday’s New England Journal of Medicine looked at how patients fared if the dose of one of the chemo drugs, daunorubicin, was doubled.

One study led by researchers at the Moffitt Cancer Center and Research Institute in Florida gave 657 leukemia patients ages 17 to 60 either the standard chemo dose or double the amount and followed them for about two years. Complete remission occurred in 71 per cent of those who took the higher dose, compared with 57 per cent in the regular dose group. Overall survival was also higher in those who had more chemo: 24 months versus 16 months.

The other study led by Erasmus University Medical Center in the Netherlands looked at an older population — ages 60 to 83 and followed them for three years. Of the 813 volunteers newly diagnosed with AML, 64 per cent in the double-dose group had complete remission compared with 54 per cent in the standard dose group. Overall, there was no difference in survival between the two groups, except those under 65 who got the double dose did better.

Just Posted

Lacombe council seeking answers about policing cost overruns

Council surprised to find out about $240,000 policing budget shortfall

Red Deer fundraiser to help educate Somali orphans on May 11

The Mother’s Day event is for all ages

Lacombe to join municipal coalition spreading the word about importance of resource industry

Resources Communities of Canada Coalition to represent municipalities connected to resource industry

These blues will get you dancing: The Overdue Blues Band performs in Red Deer Saturday

Calgary’s Brother Ray Lemelin Band is also on Elks Lodge bill

Gardening: Time and effort key to buying garden plants

Greenhouses, garden centers and box stores are set to start selling bedding… Continue reading

Montreal native Nicholas Latifi off to solid start on Formula 2 race circuit

Practice makes perfect for Canadian Nicholas Latifi. The 23-year-old Montreal auto racer… Continue reading

Bruins victory over Leafs ensures an American team will hoist the Stanley Cup

TORONTO — Many NHL players were either not yet born or too… Continue reading

Swole, buzzy, among new words in Merriam-Webster dictionary

BOSTON — Get swole, prepare a bug-out bag, grab a go-cup and… Continue reading

Garner graces cover of People’s annual ‘Beautiful Issue’

NEW YORK — Jennifer Garner graces the front of this year’s “Beautiful… Continue reading

Updated: Joshua Arthur Sanford has been found, says RCMP

37-year-old Ponoka man last seen on Tuesday morning

Inspired by a galaxy far, far away, these ‘Star Wars’ mementos could be yours forever

CHICAGO —The stuff of “Star Wars” —and there is unfortunately no better… Continue reading

Shoppers Drug Mart launches second online medical pot portal in Alberta

TORONTO — Medical cannabis users in Alberta can now get their therapeutic… Continue reading

Most Read